Sodium hydride → 3-(1-Methyl-2-butynyloxy)-5-(3,5-dimethylpiperidino)-1,2,4-thiadiazole
反応式
CS([C:4]1[N:8]=[C:7]([N:9]2[CH2:14][CH:13]([CH3:15])[CH2:12][CH:11]([CH3:16])[CH2:10]2)[S:6][N:5]=1)=O.[CH3:17][CH:18]([OH:22])[C:19]#[C:20][CH3:21].[H-].[Na+]>CN(C)C=O.COC(C)(C)C>[CH3:17][CH:18]([O:22][C:4]1[N:8]=[C:7]([N:9]2[CH2:14][CH:13]([CH3:15])[CH2:12][CH:11]([CH3:16])[CH2:10]2)[S:6][N:5]=1)[C:19]#[C:20][CH3:21]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
In 3 ml of N,N-dimethylformamide were dissolved 287 mg of 3-methylsulfinyl-5-(3,5-dimethylpiperidino)-1,2,4-thiadiazole and 103 mg of 3-pentyn-2-ol, and 58 mg of sodium hydride (oil suspension; content: 60 weight %) was added under ice-cooling. The mixture was stirred for 15 minutes and at room temperature for 1.5 hour. Furthermore, 30 mg of sodium hydride (oil suspension; content: 60 weight %) and 100 mg of 3-pentyn-2-ol were added in the mixture, and the mixture was stirred at room temperature for 30 minutes. The reaction mixture was diluted with tert-butyl methyl ether, and extracted with tert-butyl methyl ether after the addition of water. The organic layer was dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 297 mg of 3-(1-methyl-2-butynyloxy)-5-(3,5-dimethylpiperidino)-1,2,4-thiadiazole (hereinafter, referred to as the present compound (21)).
後処理
- additionwas added under ice-
- temperaturecooling
- stirringthe mixture was stirred at room temperature for 30 minutes
- extractionextracted with tert-butyl methyl ether
- additionafter the addition of water
- dry with materialThe organic layer was dried over anhydrous sodium sulfate
- concentrationconcentrated under reduced pressure
出典と根拠
- ORDレコード
- ord-b4269e750c6743138312e91d77d4eade
- 出典データセット
- uspto-grants-2008_05
- 特許番号
- US07371746B2
反応ノート
読み込み中…